Hawaii · Telemedicine
Specialized Psychiatric Care in Hawaii
Verigrate Health provides physician-led psychiatric consultation by telemedicine to appropriate patients who are physically located in Hawaii at the time of care. Christian S. Monsalve, M.D., personally evaluates diagnostic uncertainty, complex medication regimens, difficult treatment histories, psychopharmacology questions, and whether tapering or deprescribing may be clinically appropriate.
Consultation is designed for careful review rather than high-volume care. Medication reduction is never assumed; recommendations may include continuing, changing, simplifying, or gradually reducing treatment according to the clinical picture and the patient’s goals.
Consultation Focus
Clinical Questions Considered in Consultation
Diagnostic clarification when symptoms, prior diagnoses, treatment response, or medication effects do not fit a simple explanation.
Careful planning for antidepressants, benzodiazepines, sleep medicines, stimulants, or other psychiatric drugs when reduction is appropriate.
Focused review of dependence, tolerance, prior withdrawal, co-prescribed medicines, and the risks of changing or continuing treatment.
A medication-by-medication assessment of ongoing indication, benefit, burden, interactions, and opportunities to simplify safely.
Psychiatric decision-making considered alongside metabolic health, sleep, physical health, and other medically relevant factors.
Physician consultation for alcohol-related psychiatric complexity, treatment options, medication questions, and appropriate level of care.
Medication Stewardship
Psychiatric Medication Tapering in Hawaii
Psychiatric medication tapering is considered when it is clinically appropriate, not treated as the assumed goal. Review begins with the diagnosis, what each medication has helped or complicated, prior dose changes, withdrawal experiences, concurrent treatment, and the patient’s reasons for seeking consultation. A recommendation may be to continue treatment, revise it, or develop an individualized reduction plan.
Antidepressants
Review may include SSRIs and SNRIs such as sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac), venlafaxine (Effexor XR), and duloxetine (Cymbalta), along with bupropion, mirtazapine, tricyclics, and other antidepressants. Planning considers duration, prior dose changes, withdrawal sensitivity, relapse risk, and current goals.
Benzodiazepines
Medicines such as alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and diazepam (Valium) require attention to duration of use, dependence, concurrent medications, prior withdrawal, and clinical risk. If tapering is appropriate, the pace is individualized rather than predetermined.
Sleep medications and hypnotics
Consultation may review zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), orexin receptor antagonists, sedating antidepressants, and other medicines used for sleep. The assessment distinguishes insomnia, medication effects, withdrawal, and coexisting psychiatric symptoms.
Other medications used in psychiatric care
Antipsychotics, mood stabilizers, stimulant and non-stimulant ADHD treatments, anxiolytics, adjunctive medicines, and medications used for substance use disorders may also be reviewed. The purpose is to understand the complete regimen rather than isolate one prescription from the broader clinical history.
Clinical Judgment Before Reduction
A taper is not a default protocol. Recommendations weigh current benefit, adverse effects, withdrawal sensitivity, medical context, available support, and the risks of both changing and continuing treatment.
How Care Works
Physician-Led Telepsychiatry for Patients in Hawaii
Appropriate patients may receive specialized psychiatric consultation by secure telemedicine while physically located in Hawaii at the time of the appointment. The work may focus on diagnostic clarification, a difficult medication history, complex psychopharmacology, deprescribing, or a proposed taper. Care is consultative and non-emergency, and availability depends on clinical appropriateness and practice capacity.
Practice Structure
Common Questions
Is Verigrate psychiatric care available by telemedicine in Hawaii?
Yes. Verigrate offers physician-led psychiatric consultation by secure telemedicine to appropriate patients who are physically located in Hawaii at the time of care. The practice does not provide emergency, walk-in, or in-person treatment in Hawaii.
Can Verigrate evaluate a complex psychiatric medication regimen?
Yes. Consultation can examine the full regimen, the reasons each medication was started, treatment response, adverse effects, interactions, prior changes, withdrawal experiences, and unresolved diagnostic questions before recommendations are made.
Is medication tapering always the goal of consultation?
No. Tapering is considered only when clinically appropriate. A careful review may support continuing a medication, changing treatment, simplifying the regimen, or developing a gradual reduction plan.
Can benzodiazepine or antidepressant tapering be considered?
Yes. Benzodiazepine and antidepressant tapering may be considered after reviewing indication, duration, prior benefit, dependence or withdrawal history, concurrent treatment, medical factors, and the patient’s goals. A recommendation to reduce is never automatic.
How does a psychiatric consultation begin?
It begins with a comprehensive review of the clinical history. Dr. Monsalve considers prior diagnoses, medication sequence, treatment response, withdrawal experiences, relevant medical information, present concerns, and the questions the patient hopes to answer.